Literature DB >> 27621143

Exploration of the Performance of a Hybrid Closed Loop Insulin Delivery Algorithm That Includes Insulin Delivery Limits Designed to Protect Against Hypoglycemia.

Martin de Bock1,2,3, Julie Dart2, Anirban Roy4, Raymond Davey2, Wayne Soon2, Carolyn Berthold2, Adam Retterath2, Benyamin Grosman4, Natalie Kurtz4, Elizabeth Davis1,2,3, Timothy Jones1,2,3.   

Abstract

BACKGROUND: Hypoglycemia remains a risk for closed loop insulin delivery particularly following exercise or if the glucose sensor is inaccurate. The aim of this study was to test whether an algorithm that includes a limit to insulin delivery is effective at protecting against hypoglycemia under those circumstances.
METHODS: An observational study on 8 participants with type 1 diabetes was conducted, where a hybrid closed loop system (HCL) (Medtronic™ 670G) was challenged with hypoglycemic stimuli: exercise and an overreading glucose sensor.
RESULTS: There was no overnight or exercise-induced hypoglycemia during HCL insulin delivery. All daytime hypoglycemia was attributable to postmeal bolused insulin in those participants with a more aggressive carbohydrate factor.
CONCLUSION: HCL systems rely on accurate carbohydrate ratios and carbohydrate counting to avoid hypoglycemia. The algorithm that was tested against moderate exercise and an overreading glucose sensor performed well in terms of hypoglycemia avoidance. Algorithm refinement continues in preparation for long-term outpatient trials.

Entities:  

Keywords:  closed loop; continuous glucose monitoring; hypoglycemia; type 1 diabetes

Mesh:

Substances:

Year:  2016        PMID: 27621143      PMCID: PMC5375079          DOI: 10.1177/1932296816668876

Source DB:  PubMed          Journal:  J Diabetes Sci Technol        ISSN: 1932-2968


  9 in total

1.  Day and Night Closed-Loop Control Using the Integrated Medtronic Hybrid Closed-Loop System in Type 1 Diabetes at Diabetes Camp.

Authors:  Trang T Ly; Anirban Roy; Benyamin Grosman; John Shin; Alex Campbell; Salman Monirabbasi; Bradley Liang; Rie von Eyben; Satya Shanmugham; Paula Clinton; Bruce A Buckingham
Journal:  Diabetes Care       Date:  2015-06-06       Impact factor: 19.112

2.  Day and night home closed-loop insulin delivery in adults with type 1 diabetes: three-center randomized crossover study.

Authors:  Lalantha Leelarathna; Sibylle Dellweg; Julia K Mader; Janet M Allen; Carsten Benesch; Werner Doll; Martin Ellmerer; Sara Hartnell; Lutz Heinemann; Harald Kojzar; Lucy Michalewski; Marianna Nodale; Hood Thabit; Malgorzata E Wilinska; Thomas R Pieber; Sabine Arnolds; Mark L Evans; Roman Hovorka
Journal:  Diabetes Care       Date:  2014-07       Impact factor: 19.112

3.  Exercise, hypoglycemia, and type 1 diabetes.

Authors:  Rita Basu; Matthew L Johnson; Yogish C Kudva; Ananda Basu
Journal:  Diabetes Technol Ther       Date:  2014-05-08       Impact factor: 6.118

Review 4.  Current perspectives on physical activity and exercise for youth with diabetes.

Authors:  Jacklyn A Pivovarov; Craig E Taplin; Michael C Riddell
Journal:  Pediatr Diabetes       Date:  2015-03-09       Impact factor: 4.866

5.  Outpatient glycemic control with a bionic pancreas in type 1 diabetes.

Authors:  Steven J Russell; Firas H El-Khatib; Manasi Sinha; Kendra L Magyar; Katherine McKeon; Laura G Goergen; Courtney Balliro; Mallory A Hillard; David M Nathan; Edward R Damiano
Journal:  N Engl J Med       Date:  2014-06-15       Impact factor: 91.245

6.  Home Use of an Artificial Beta Cell in Type 1 Diabetes.

Authors:  H Thabit; M Tauschmann; J M Allen; L Leelarathna; S Hartnell; M E Wilinska; C L Acerini; S Dellweg; C Benesch; L Heinemann; J K Mader; M Holzer; H Kojzar; J Exall; J Yong; J Pichierri; K D Barnard; C Kollman; P Cheng; P C Hindmarsh; F M Campbell; S Arnolds; T R Pieber; M L Evans; D B Dunger; R Hovorka
Journal:  N Engl J Med       Date:  2015-09-17       Impact factor: 91.245

7.  Overnight closed loop insulin delivery (artificial pancreas) in adults with type 1 diabetes: crossover randomised controlled studies.

Authors:  Roman Hovorka; Kavita Kumareswaran; Julie Harris; Janet M Allen; Daniela Elleri; Dongyuan Xing; Craig Kollman; Marianna Nodale; Helen R Murphy; David B Dunger; Stephanie A Amiel; Simon R Heller; Malgorzata E Wilinska; Mark L Evans
Journal:  BMJ       Date:  2011-04-13

8.  Predictive Low-Glucose Insulin Suspension Reduces Duration of Nocturnal Hypoglycemia in Children Without Increasing Ketosis.

Authors:  Bruce A Buckingham; Dan Raghinaru; Fraser Cameron; B Wayne Bequette; H Peter Chase; David M Maahs; Robert Slover; R Paul Wadwa; Darrell M Wilson; Trang Ly; Tandy Aye; Irene Hramiak; Cheril Clarson; Robert Stein; Patricia H Gallego; John Lum; Judy Sibayan; Craig Kollman; Roy W Beck
Journal:  Diabetes Care       Date:  2015-06-06       Impact factor: 19.112

9.  Reduced hypoglycemia and increased time in target using closed-loop insulin delivery during nights with or without antecedent afternoon exercise in type 1 diabetes.

Authors:  Jennifer L Sherr; Eda Cengiz; Cesar C Palerm; Bud Clark; Natalie Kurtz; Anirban Roy; Lori Carria; Martin Cantwell; William V Tamborlane; Stuart A Weinzimer
Journal:  Diabetes Care       Date:  2013-06-11       Impact factor: 19.112

  9 in total
  8 in total

Review 1.  Artificial Pancreas Systems and Physical Activity in Patients with Type 1 Diabetes: Challenges, Adopted Approaches, and Future Perspectives.

Authors:  Sémah Tagougui; Nadine Taleb; Joséphine Molvau; Élisabeth Nguyen; Marie Raffray; Rémi Rabasa-Lhoret
Journal:  J Diabetes Sci Technol       Date:  2019-08-13

Review 2.  A Review of the Current Challenges Associated with the Development of an Artificial Pancreas by a Double Subcutaneous Approach.

Authors:  Sverre Christian Christiansen; Anders Lyngvi Fougner; Øyvind Stavdahl; Konstanze Kölle; Reinold Ellingsen; Sven Magnus Carlsen
Journal:  Diabetes Ther       Date:  2017-05-13       Impact factor: 2.945

3.  Glucose Outcomes with the In-Home Use of a Hybrid Closed-Loop Insulin Delivery System in Adolescents and Adults with Type 1 Diabetes.

Authors:  Satish K Garg; Stuart A Weinzimer; William V Tamborlane; Bruce A Buckingham; Bruce W Bode; Timothy S Bailey; Ronald L Brazg; Jacob Ilany; Robert H Slover; Stacey M Anderson; Richard M Bergenstal; Benyamin Grosman; Anirban Roy; Toni L Cordero; John Shin; Scott W Lee; Francine R Kaufman
Journal:  Diabetes Technol Ther       Date:  2017-01-30       Impact factor: 6.118

Review 4.  Efficacy and safety of the artificial pancreas in the paediatric population with type 1 diabetes.

Authors:  Susanna Esposito; Elisa Santi; Giulia Mancini; Francesco Rogari; Giorgia Tascini; Giada Toni; Alberto Argentiero; Maria Giulia Berioli
Journal:  J Transl Med       Date:  2018-06-28       Impact factor: 5.531

5.  The Closed-Loop System Improved the Control of a Pregnant Patient with Type 1 Diabetes Mellitus.

Authors:  Guillermo E Guzmán Gómez; Julian A Viggiano; A Silva-De Las Salas; Veline Martínez; María A Urbano Bonilla
Journal:  Case Rep Endocrinol       Date:  2021-09-21

Review 6.  Protective effects of physical activity against health risks associated with type 1 diabetes: "Health benefits outweigh the risks".

Authors:  Addisu Dabi Wake
Journal:  World J Diabetes       Date:  2022-03-15

7.  Editorial: Physical Activity and Type 1 Diabetes.

Authors:  Johan H Jendle; Michael C Riddell
Journal:  Front Endocrinol (Lausanne)       Date:  2019-12-06       Impact factor: 5.555

8.  Safely finishing a half marathon by an adult with type 1 diabetes using a commercially available hybrid closed-loop system.

Authors:  Louisa van den Boom; Haris Ziko; Julia K Mader
Journal:  J Diabetes Investig       Date:  2020-08-08       Impact factor: 4.232

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.